Evidence map›Paper›PMID 33284786›Full record

ArticlePhysics in medicine and biology2020

Clinical translation of a new flat-panel detector for beam's-eye-view imaging.

T C Harris, J Seco, D Ferguson, M Lehmann, P Huber, M Shi, M Jacobson, I Valencia Lozano, M Myronakis, P Baturin and 3 more

Abstract read
In one paragraph

Article in Physics in medicine and biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

T C HarrisDepartment of Radiation Oncology, Dana Farber/Brigham and Women's Cancer Center, Harvard Medical school, Boston, MA, United States of America.
J SecoBioMedical Physics in Radiation Oncology, DKFZ, Heidelberg, Germany.
D FergusonDepartment of Radiation Oncology, Dana Farber/Brigham and Women's Cancer Center, Harvard Medical school, Boston, MA, United States of America.
M LehmannVarian Medical Systems, Baden-Dattwil, Switzerland.
P HuberVarian Medical Systems, Baden-Dattwil, Switzerland.
M ShiDepartment of Radiation Oncology, Dana Farber/Brigham and Women's Cancer Center, Harvard Medical school, Boston, MA, United States of America.
M JacobsonDepartment of Radiation Oncology, Dana Farber/Brigham and Women's Cancer Center, Harvard Medical school, Boston, MA, United States of America.
I Valencia LozanoDepartment of Radiation Oncology, Dana Farber/Brigham and Women's Cancer Center, Harvard Medical school, Boston, MA, United States of America.
M MyronakisDepartment of Radiation Oncology, Dana Farber/Brigham and Women's Cancer Center, Harvard Medical school, Boston, MA, United States of America.
P BaturinVarian Medical System, Palo Alto, CA, United States of America.
R FueglistallerVarian Medical Systems, Baden-Dattwil, Switzerland.
D MorfVarian Medical Systems, Baden-Dattwil, Switzerland.
R BerbecoDepartment of Radiation Oncology, Dana Farber/Brigham and Women's Cancer Center, Harvard Medical school, Boston, MA, United States of America.

Funding

A novel flat-panel detector for advanced on-board radiation therapy imagingR01CA188446 · NCI · DANA-FARBER CANCER INST · PI BERBECO, ROSS I., FUEGLISTALLER, RONY · 2014 to 2024
$7.2M
NCI NIH HHS R01 CA188446
6 · The paper itself

Abstract

Electronic portal imaging devices (EPIDs) lend themselves to beams-eye view clinical applications, such as tumor tracking, but are limited by low contrast and detective quantum efficiency (DQE). We characterize a novel EPID prototype consisting of multiple layers and investigate its suitability for use under clinical conditions. A prototype multi-layer imager (MLI) was constructed utilizing four conventional EPID layers, each consisting of a copper plate, a Gd2O2S:Tb phosphor scintillator, and an amorphous silicon flat panel array detector. We measured the detector's response to a 6 MV photon beam with regards to modulation transfer function, noise power spectrum, DQE, contrast-to-noise ratio (CNR), signal-to-noise ratio (SNR), and the linearity of the detector's response to dose. Additionally, we compared MLI performance to the single top layer of the MLI and the standard Varian AS-1200 detector. Pre-clinical imaging was done on an anthropomorphic phantom, and the detector's CNR, SNR and spatial resolution were assessed in a clinical environment. Images obtained from spine and liver patient treatment deliveries were analyzed to verify CNR and SNR improvements. The MLI has a DQE(0) of 9.7%, about 5.7 times the reference AS-1200 detector. Improved noise performance largely drives the increase. CNR and SNR of clinical images improved three-fold compared to reference. A novel MLI was characterized and prepared for clinical translation. The MLI substantially improved DQE and CNR performance while maintaining the same resolution. Pre-clinical tests on an anthropomorphic phantom demonstrated improved performance as predicted theoretically. Preliminary patient data were analyzed, confirming improved CNR and SNR. Clinical applications are anticipated to include more accurate soft tissue tracking.

Indexed as

Electrical Equipment and SuppliesDiagnostic ImagingHumansPhantoms, ImagingSignal-To-Noise RatioTranslational Research, Biomedical

Identifiers

PMID33284786
PMCPMC9142212

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.